Next Article in Journal
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens
Previous Article in Journal
Knowledge, Attitudes, and Practices in Antibiotic Dispensing amongst Pharmacists in Trinidad and Tobago: Exploring a Novel Dichotomy of Antibiotic Laws
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Enhancing the Antibiotic Production by Thermophilic Bacteria Isolated from Hot Spring Waters via Ethyl Methanesulfonate Mutagenesis

by
Yasmin G. Kortam
1,
Wafaa M. Abd El-Rahim
1,*,
Abd El-Nassar A. Khattab
2,
Nazih Y. Rebouh
3,
Regina R. Gurina
4,
Olfat S. Barakat
5,
Mohamed Zakaria
5 and
Hassan Moawad
1
1
Department of Agricultural Microbiology, National Research Centre, Giza 12622, Egypt
2
Department of Genetics and Cytology, National Research Centre, Cairo 12622, Egypt
3
Department of Environmental Management, Institute of Environmental Engineering, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia
4
Technosphere Security Department, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia
5
Department of Agricultural Microbiology, Faculty of Agriculture, Cairo University, Cairo 12613, Egypt
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(7), 1095; https://doi.org/10.3390/antibiotics12071095
Submission received: 14 April 2023 / Revised: 18 June 2023 / Accepted: 19 June 2023 / Published: 23 June 2023

Abstract

:
Antibiotic-resistant bacteria represent a serious public health threat. For that reason, the development of new and effective antibiotics to control pathogens has become necessary. The current study aims to search for new microorganisms expressing antibiotic production capacity. Fifteen sites covering a wide range of harsh environmental conditions in Egypt were investigated. Two hundred and eighty bacterial isolates were obtained and then tested against pathogenic bacteria using the agar disk diffusion technique. Fifty-two (18.6% of the total) of the isolates exhibited antagonistic properties, which affected one or more of the tested pathogens. The isolate 113 was identified as Bacillus licheniformis and isolate 10 was identified as Brevibacillus borstelensis using the 16S rRNA technique. The B. licheniformis strain was stronger in antibiotic production against S. typhi, M. luteus, and P. ariginosa, whereas the strain Br. borstelensis was more efficient against B. cereus, E. coli, and Klebs. sp. The sensitivity of the strains to commercial antibiotics showed that B. licheniformis was highly sensitive to seven commercial antibiotics, whereas Br. borstelensis was sensitive to nine antibiotics. The two strains were subjected to ethyl methanesulfonate (EMS) mutagenesis to obtain mutants with a higher antibiotic production. The total bacterial count was measured after treatment with EMS mutagen and showed a significant gradual increase in the antimicrobial activity, which was achieved via shaking in the presence of EMS for 60 min. High antimicrobial activities were noted with 17 and 14 mutants from the B. licheniformis and Br. borstelensis strains, respectively. The mutant B. licheniformis (M15/Amo) was more active than the parent strain against S. aureus (212.5%), while the mutant Br. borstelensis (B7/Neo) was more effective against S. typhi (83.3%). The present study demonstrates the possibility of obtaining potent antibiotic-producing bacteria in hot spring waters and further improving the indigenous bacterial capacity to produce antibiotics by using EMS mutagenesis.

1. Introduction

Antibiotics are small bioactive molecules that are naturally produced by microorganisms like bacteria and fungi during their secondary metabolism [1,2]. In 1941, the term “antibiotics” was first used by Selman Waksman to describe microscopic substances produced by microorganisms that prevent the growth of other germs [3]. The development of penicillin, which is made by a fungus, as well as the development of streptomycin, chloramphenicol, and tetracycline, which are made by soil bacteria, initiated the antibiotic era between 1945 and 1955 [4]. These original antibiotics are now mainly ineffective due to the evolution of antibiotic resistance by significant human diseases, and if replacements are not discovered, the golden age of antibiotics will soon come to an end [5,6].
The increasing prevalence of antibiotic resistance reduced or abolished the in vivo efficacy of antibiotics, and the spread of antibiotic-resistant microorganisms is now threatening the treatment of infectious diseases [7,8]; therefore, the need for research on antimicrobial agents to overcome this serious threat to human, animal, and plant health is becoming a priority to control the spread of antibiotic-resistant pathogens [9] that cause life-threatening diseases [10].
It is known that terrestrial and aquatic environments represent the natural reservoir of a wide range of microorganisms that interact with each other [11,12]. Microbial metabolites produced in this interaction are rich sources of new potential bioactive compound [13,14].
The antimicrobial activity of certain bacteria represents an important tool for defending the microbial persistence of many microorganisms in soil and water [15,16,17].
A good method for obtaining novel bioactive compounds is to harbor antibiotic activity [18,19]. Only about 100 antibiotics have been used commercially out of the 5000 antibiotics produced by the cultures of Gram-positive bacteria, Gram-negative bacteria, and filamentous fungus [20]. To combat the resistance to the currently available antibiotics, researchers must look for less harmful, more effective antibiotics from non-infectious organisms [21]. The bacteria that have evolved to withstand situations with minimal water availability, high salinity, extreme temperatures, and pH could be sources of novel bioactive chemicals [22,23]. The aquatic and terrestrial ecosystems in Egypt are rich in native microbes, many of which are tolerant to various stress conditions [23,24,25].
Numerous studies were conducted to optimize the microbial culture conditions to increase the effectiveness of antibiotics [26] using genetic improvement protocols [27]. Chemical mutagenesis via ethyl methanesulfonate (EMS) was used to obtain stable mutants with enhanced antimicrobial production [28].
The aim of this work is to search for potent antibiotic-producing bacteria inhabiting extreme environments and to improve the antibiotic production by promising strains that are capable of producing antibiotics against certain pathogenic bacteria.

2. Results

2.1. Hot Spring Water and Saline-Affected Soils Used for Microbial Isolation

The temperature of seven hot springs recorded from Sinai, Wadi El-Natrun, and Dakhala and Kharga Oasis ranged between 50 and 90 °C, with samples from the Ras Sedr sulfur hot springs being the highest (90 °C), and Hammam Pharaon being the lowest (50 °C). The electric conductivity of the water sample was measured in the range of 7.05–9.66 ds/m in samples obtained from Sinai and Wadi El-Natrun hot springs. However, in the samples collected from the Oasis sites, the EC was 8.16 in the Dakhala Oasis sample and 9.66 ds/m in the Kharga Oasis hot spring sample. These two samples showed the lower value of dissolved cations and anions compared with all other spring water. The dissolved Na+ was high in the samples from Wadi El-Natrun. The data in Table 1 show a wide range of the chemical properties of hot spring waters collected from the geographical zones in Egypt.
Regarding the analysis of soils affected by hot spring water and salinity conditions, the temperatures of the soils around hot springs were as high as the hot spring water (50–90 °C). The electric conductivity and sodium content of the Wadi El-Natrun lake soil and soil collected from the rhizosphere of plants growing in the Suez Gulf coastal area in Sinai, the hot spring water, and the salt-affected soils were selected to cover a wide range of microbial conditions to obtain the diversity of microbes needed for further testing of antibiotic production under these harsh conditions.

2.2. Isolation of Thermophilic and Halophilic Microbes

Fifteen sites covering a wide range of extreme conditions were explored for the presence of antibiotic-producing microbes. These sites included 11 hot spring sites at Sinai, Wadi EL-Natrun, Suez Gulf, Hammam Pharaon, Ras Sedr, and Dakhla and Kharga Oasis at New Valley. Four additional sites were included for the isolation of the antibiotic-producing microbes from salt-affected soils at Sinai, Wadi El-Natrun, and the Suez Gulf coastal zone. The total isolates from all 15 of the above mentioned samples totaled 280 bacterial isolates, as seen in Table 2. Based on the zone of inhibition observed on agar plates, antibiotic-producing microbes were screened. Out of 280 bacterial isolates, only 52 bacterial isolates were antibiotic-producing bacteria. The phenotypic differentiation among the fifty-two antimicrobial-producing bacterial isolates based on colony and cell morphology as well as Gram staining showed that all of the isolates were Gram positive, except for isolates No. 8, 118, 131, 135, and 184, which were Gram negative. The contents of the 52 antibiotic-producing bacterial isolates were found to be bacteria of the bacilli except for those found in isolates No. 19, 122, 130, 191, and 229, which were streptococci based on their morphological appearance, as observed under the microscope.

2.3. Screening Isolates for Antibiotic Production Using Standard Agar Disc Diffusion (SADD) Method

The testing of these isolates against eight pathogenic test bacteria showed that only 52 isolates (18.6%) were capable of showing antagonistic activity against one or more of the pathogenic test organisms. The antibiotic-producing bacteria collected from hot water samples amounted 38 isolates (13.6%) of the total bacterial isolates, whereas the antibiotic-producing isolates from soils did not exceed 5% of the total. Some hot spring water samples were marked by a higher percentage of isolates that produce antibiotics. In the samples from the Dakhla Oasis, Hammam Pharaon hot spring, Ras Sedr hot springs, and Kharga Oasis hot spring, the percentage of antibiotic-producing bacteria amounted 46.1, 33.3, 29.4, and 26.3% of the isolates from these tested samples, respectively. Regarding the presence of antibiotic-producing bacteria in soils affected by hot spring water and salinity conditions, the isolates producing at the highest percentages of the total isolates from the same site were from the soil affected by the Hammam Pharaon hot spring water at 28.5% followed by 15.7% among all isolates from the rhizosphere sample affected by the Suez Gulf saline water (Table 2, Figure 1).
The antibiotic production profiles (APP) of the fifty-two isolates collected from the hot spring water and soils affected by hot spring waters and saline conditions are presented in Table 3. According to the research, the isolates from the hot spring waters were often more capable of producing antibiotics than those isolated from saline soils. All isolates were divided into 35 antibiotic production profiles, including 24 from hot water sources and 11 from soils affected by hot waters and salinity. The broad-spectrum range of several isolates from hot waters was higher than those from soils (Table 3). From the first nine sites of hot water sampling, 13 isolates antagonized six pathogenic tests. However, only one soil sample affected by the hot spring water yielded two isolates that were capable of antagonizing seven pathogenic tests. Isolates 10 and 113 isolated from the Kharga Oasis and Hammam Pharaon hot springs were the broadest spectrum, as all the test pathogens were killed by the antibiotics produced by these isolates, with a wide diversity of isolates in relation to antibiotic production. The least active isolate was from the soil affected by the Hammam Pharaon hot water, where only the isolate 156 was capable of antagonizing B. subtilis (Table 3).

2.4. Molecular Identification of the Potent Antibiotic-Producing Bacterial Isolates 10 and 113

Nearly full-length 16S rRNA gene products (1500 bp) were amplified and sequenced from the potent antibiotic-producing bacterial isolates 10 and 113. The sequences of the 16S rRNA gene were blasted to the EZBioCloud database. The sequences of the 16S rRNA gene from isolates 113 shared 97.83% similarity with Bacillus licheniformis strain AT59. The 16S rRNA sequence of isolate 10 displayed a high similarity of 97.41% with Brevibacillus borstelensis MA-49 (KX426649.1).
Based on the ML phylogenetic tree utilizing 16S rRNA sequences, the bacterial isolates were closely affiliated to two genera, Bacillus and Brevibacillus, and were grouped in two distinct clusters (Figure 2). Due to the low phylogenetic power at the species level, the newly isolated bacteria in this study were assigned only to the genus level, isolate 113 was identified as Bacillus sp. and tightly grouped with type strains of Bacillus licheniformis, Bacillus aerius, Bacillus haynesii, Bacillus sonorensis, and Bacillus swezeyi, supported by a 100% BT value. Isolate No. 10 was assigned to Brevibacillus sp. and grouped with species of Brevibacillus fulvus, Brevibacillus levickii, Brevibacillus borstelensis, Brevibacillus centrosporus, Brevibacillus panacihumi, and Brevibacillus invocatus (100% BT, 99.6% ANI).

2.5. Antimicrobial Inhibitory Effect of Two Potent Bacterial Supernatants against Test Pathogenic Bacteria

The degree of antagonism by the two selected strains, B. licheniformis 113 and Br. borstelensis 10, isolated from hot spring waters, was further assessed using the antimicrobial inhibitory effect of cultural supernatant against eight pathogenic test bacteria. A total of 25 μL of the cultural supernatant was loaded on filter discs and placed on the growth of the test bacteria Figure 3. The results in Table 4 show that the supernatant of B. licheniformis 113 was stronger in the antagonism against E. coli, K. pneumonia, B. cereus, B. subtilis, and P. ariginosa compared with the supernatant from Br. borstelensis 10. The latter was, on the contrary, more potent against P. aeruginosa, E. coli, B. cereus, and M. luteus. Despite the difference in the antimicrobial inhibitory effect of both strains, the strains seem to have a strong specific inhibitory effect against the tested pathogenic bacteria.

2.6. Mutagenesis Using Ethyl Methanesulfonate (EMS)

Before mutation induction, a good selective method to isolate mutants with heterogeneous genotypes must be found. Here, we used the response to antibiotics as a strong selective method by measuring the resistance and sensitivity of many antibiotic discs. Antibiotic discs were used, which were strong in killing the bacterial strains under study, and gave the largest area of inhibition to serve as detectors for colonies that can grow in large areas of inhibition around such type of antibiotics after the mutation induction via chemical mutagen. The resistance of B. licheniformis 113 and Br. borstelensis 10 to 13 preloaded commercial antibacterial discs were assessed.
The results show a high sensitivity of B. licheniformis 113, measured by the diameter of inhibition zones to rifampicin-SV (26 mm), followed by chloramphenicol (18 mm), polymyxin B (16 mm), norfloxacin (12 mm), gentamycin (11 mm), tetracycline (8 mm), and amoxycillin (8 mm). The strain was resistant to six antibiotics, namely, vancomycin, oxytetracycline, neomycin, kanamycin, streptomycin, and erythromycin (Table 4). In contrast, Br. borstelensis 10 was resistant to vancomycin, rifamycin-SV, amoxycillin, and streptomycin. This strain was sensitive to eight antibiotics, especially chloramphenicol (24 mm), followed by norfloxacin (16 mm) and erythromycin (15 mm) (Table 5).

2.7. Genetic Improvement of Antimicrobial-Producing Strains via Ethyl Methanesulfonate (EMS) Mutagenesis

The EMS technique was used to perform chemical mutagenesis on B. licheniformis 113 and Br. borstelensis 10 strains to increase antibiotic production. The mutant antibiotic-producing bacterial strain counts were measured at different shaking periods. The results show that the total number of bacteria gradually decreased with continuous shaking for 60 min. This may be due to the direct toxic effect of EMS on bacterial cells (Table 5). The antibiotic production by living mutant bacterial strains against test pathogenic bacteria at different shaking periods was studied. Table 6 shows a significant gradual increase in antimicrobial activity with continuous shaking for 60 min. This indicates the positive effect of the mutagenic process on the antimicrobial production by the bacterial strains used.
In general, 17 and 14 antibiotic-resistant mutants were selected from the strains B. licheniformis 113 and Br. borstelensis 10, respectively, and the evaluations of their antibacterial activity are shown in Table 7 and Table 8. The antimicrobial effects of mutagenic B. licheniformis 113 against pathogenic test bacteria are shown in Table 7. All the mutants (M 1 to M 17) demonstrated higher activity against all the test bacteria when compared to those that the parental strains did. Mutant M 15 recorded as the highest antimicrobial activity against all pathogenic bacteria, followed by M 8, compared to the parental strains as follows:
( Efficiency = Mutant   activity Parant   activity Mutant   activity × 100 )
The improvement range for M 15 was from 59.1 (E. coli) to 212.5% (S. aureus), while it was from 50 (B. cereus and S. typhi) to 175.1% (M. luteus) for the mutant M8. In contrast, the mutants B7 and B11 represented the highest antimicrobial activities against most pathogenic bacteria, respectively, compared to those of the parental strains. The mutant B7 represented the highest antimicrobial activities against most pathogenic test bacteria ranging from 21.05 (K. pneumoniae) to 83.3% (S. typhi), while the mutant B11 showed an improvement range from 40.2 (E. coli) to 100.1% (St. aureus). According to the aforementioned EMS mutant’s data, all the obtained mutants exhibited an improvement in their anti-microbial activity against all pathogenic testers, and the improvement percentage in the case of B. licheniformis 113 varied from 312.5 (M15/AMX against to S. aureus) to 104.55 (M7/OXY against to B. subtilis), whereas in the case of strain B. borstelensis 10, the improvement rate ranged from 200 (B11/PM-B against to S. aureus) to 105.55 (B3/GEN against to S. typhi) (Table 8).

3. Discussion

The need to develop new antimicrobial substances is growing, since many traditional commercial antibiotics have lost their efficiency due to the multidrug resistance of pathogens to widely used antimicrobials. This study is one of the trails used to explore potential new chemical antibiotics, particularly, marginal studies environments, such as places exposed to high temperatures and salinity. This approach was also studied by other authors [29,30,31,32,33].
Seven hot spring water samples and five soil samples, two of which were affected by salinity and three affected by hot spring waters, were used for the isolation of antibiotic-producing microorganisms. Among the 280 isolates obtained from the 15 sites, 52 isolates possessed the capacity to produce antimicrobials against test pathogens used in this study. The ratio of antibiotic-producing microorganisms to non-antibiotic-producing microorganisms is in line with the findings of other authors [34,35]. Regarding the presence of antibiotic-producing bacteria in soils affected by hot spring waters and salinity conditions, the isolates producing at the highest percentages of the total isolates from the same site were from the soil affected by the Hammam Pharaon hot spring water at 28.5% followed by 15.7% among all isolates from the rhizosphere sample affected by the Suez Gulf saline water. Antimicrobial production via thermophilic and halophilic bacteria isolated from extreme conditions was stated in several reports [36,37].
The broad-spectrum range of several isolates from the hot spring waters was higher than those from the soil samples. From the first nine sites of hot water sampling, 13 isolates antagonized six pathogenic tests. However, only one soil sample affected by the hot spring water gave two isolates that were capable of antagonizing seven pathogenic test organisms. Isolates 10 and 113 isolated from the Kharga Oasis and Hammam Pharaon hot springs had the broadest antibiotic spectrum among all of the isolates. The test pathogens used in this study were killed by the antibiotics produced by these isolates. The least active isolate was from the soil affected by the Hammam Pharaon hot spring water, where only the isolate 156 was capable of antagonizing B. subtilis. The differences in the antibiotic production by microbes isolated from similar sites were previously stated in [38,39].
The two potent isolates in antibiotic production, isolate No. 113 from the Kharga Oasis water sample and isolate No. 10 from the Hamam Pharaon water springs, were identified using the 16S rRNA technique. The sequences of the 16S rRNA gene from isolate 113 shared 97.83% similarity with the Bacillus licheniformis strain AT59, whereas the 16S rRNA sequence of isolate 10 displayed a high similarity of 97.41% with Brevibacillus borstelensis MA-49 (KX426649.1).
The supernatant of strain B. licheniformis 113 was stronger in the antagonism against S. typhi, S. aureus, M. luteus, and P. ariginosa compared with the supernatant from Br. borstelensis 10. The latter was, on the contrary, more potent against B. cereus, E. coli, and K. pneumonia. Despite the difference in the minimal inhibitory effect of MIE on both strains, the strains seem to have a strong specific inhibitory effect against the tested pathogenic bacteria. The antimicrobial inhibitory effects of B. licheniformis and Br. borstelensis were also studied previously [40,41].
The sensitivity of the B. licheniformis 113 obtained in this study showed the diameter of the inhibition zones to rifampicin-SV (26 mm), followed by chloramphenicol (18 mm), polymyxin B (16 mm), norfloxacin (12 mm), gentamycin (11 mm), tetracycline (8 mm), and amoxycillin (8 mm). This strain was resistant against six antibiotics, namely, vancomycin, oxytetracycline, neomycin, kanamycin, streptomycin, and erythromycin. The strain Br. borstelensis 10 was resistant against vancomycin, rifamycin-SV, amoxycillin, and streptomycin. This strain was sensitive to eight antibiotics, especially chloramphenicol (24 mm), followed by norfloxacin (16 mm) and erythromycin (15 mm). Therefore, the antibiotics were used as markers to select the most resistant mutants [42,43,44].
The genetic improvement in the antibiotic production by two potential strains using EMS mutagenesis was studied. In nature, mutations occur at extremely low rates. Due to the exposure to various mutagenic agents, mutations can occur in changes in the nucleotide sequences of DNA (e.g., point mutations, double mutations, deletions, and insertions). Induced mutagenesis is a common technique for creating new mutant strains with better characteristics. The most common mutagen used to enhance bacterial strains is EMS, which causes a variety of point mutations in the bacterial DNA. Exceptional mutants are formed at increasing quantities as a result of these point modifications, in conjunction with regular adjustments to enhance the antibiotic production [45,46].
The total number of bacteria after treatment gradually decreased with continuous shaking for 60 min. This may be due to the direct toxic effect of EMS on bacterial cells. The antibiotic production by living mutant bacterial strains against test pathogenic bacteria at different shaking periods was studied. A significant gradual increase in the antimicrobial activity with continuous shaking for 60 min was recorded. This indicates the positive effect of the mutagenic process on the antimicrobial production by the bacterial strains used. Antimicrobial stimulation via EMS mutagenesis was stated in previous studies [46,47,48].
McAuley et al. [49] discovered that the possessed resistance genes for the antimicrobial molecules they produce are often related to and coregulated with antibiotic production genes. The overproduction of the secondary metabolite actinorhodin via strR mutations of S. coelicolor was reported in [50]; it was also reported by El-Bondkly and Khattab [51], who detected that clavulanic acid and cephamycin improvement in Streptomyces clavuligerus happens by promoting combination resistance mutations and protoplast fusion. The antibacterial agents (bacteriocins) of probiotic bacteria were enhanced via UV, NTG, and EMS, and improvements of 290%, 266%, and 345.7% were achieved. El-Sherbini and Khattab [28] found that the lincomycin produced by Streptomyces lincolnensis increased by 1.5-fold via the induction of novel mutants using ultra-violet (UV) irradiation and ethyl methanesulfonate (EMS). Finally, Qattan and Khatab [52] demonstrated that genetically enhanced mutants of Micromonospora echinospora increased gentamicin production, and mutants of Streptomyces albogriseolus improved neomycin production.
The results clearly show that exploring the antibiotic production by native microbes inhabiting the less studied harsh environments is a promising approach for the isolation of potential microbial resources for antibiotic production. The additional genetic improvement in potential strains has proven to be among the techniques for a better production of antimicrobials. The continuous efforts in this direction will pave the way for combating the multidrug resistance phenomenon threatening the life of patients suffering from serious diseases.

4. Material and Methods

4.1. Collection of Samples from Extreme Conditions

Figure 4 shows water samples from hot springs and soils close by that were collected from several locations in Egypt including Hammam Pharaon, the Closed Sulfur Lake at Ras Sedr at Sinai, and the Closed Dakhla as well as Kharga lakes. Samples affected by high salinity were obtained from different lakes, such as Red Lake, Gaar Lake, and Al-Beuda Lake at Wadi-Natrun, Egypt. Samples of hot springs were collected in double-walled containers to maintain the temperature until analysis. Samples of salt lakes were obtained in sterile plastic containers and kept in an ice box and then in a refrigerator at 4 °C until analysis. Using a random sampling technique, soil samples were taken from the study area at a depth of 5–10 cm and kept in sterile polyethylene bags at 4 °C until analysis. All samples were examined according to APHA (American Public Health Association) guidelines [53].

4.2. Isolation of Thermophilic and Halophilic Microbes

Using the serial dilution agar plate technique, microbes were recovered from soil and water samples. Nine milliliters of sterile distilled water was combined with one milliliter of each water sample or one gram of each soil sample, and the mixtures were serially diluted up to a 10−6 fold dilution. Using the same water source, an aliquot of 0.1 mL of each dilution was used to inoculate the nutrient agar (NA) medium for isolating bacteria, the starch casein (SC) medium was used for isolating actinomycetes, and the potato dextrose agar (PDA) medium was used for isolating fungi. The sterilization process was placed at 121 °C for 20 min. The plates were inoculated using the spread plate method and incubated at 60 °C for 2 days for the thermophilic bacteria, 5 days for thermophilic fungi, and 7 days for thermophilic actinomycetes. Isolation of halophilic bacteria was performed via incubation at 30 °C for 2 days for the halophilic bacteria, 5 days for halophilic fungi, and 7 days for halophilic actinomycetes. From each plate, a single colony was selected and purified via streaking [54,55].

4.3. Screening Isolates for Antibiotic Production Using Standard Agar Disc Diffusion (SADD) Method

The microbial isolates were assessed for antibiotic production using the SADD method against 8 pathogenic bacteria. The tested bacterial isolates were the following: Klebsiella pneumonia ATCC7000603, Escherichia coli ATCC25922, Bacillus subtilis ATCC6633, Bacillus cereus ATCC14579, Staphylococcus aureus ATCC6538, Micrococcus luteus ATCC10240, Pseudomonas ariginosa ATCC9027, and Salmonella typhi ATCC14028. The thermophilic isolates were grown at 50 °C for 48 h on a shaker (120 rpm) in 100 mL of nutrient broth media prepared by using the same original source of water. The halophilic microbes were grown at 30 °C. The test strains were grown in 100 mL of nutrient broth media and incubated at 37 °C for 24 h. The optical density of broth cultures was determined using the UV–VIS spectrophotometer (Bio Chrome Libra S70) at λ600 nm to standardize microbial growth above 0.6. Fungal filtrates were separated via filtration using Whatman, No. 0.1, whereas bacterial culture supernatant was separated via centrifugation (6000 rpm, 4 °C, 15 min). To ensure that the bacteria were evenly distributed across the agar medium, 1 ml of the bacterial test strain inoculum suspension was spread over the media using a sterile glass rod. Twenty microliters of microbial isolates filtrates/supernatants was loaded on paper discs. Paper diffuse discs were made from the media and then arranged on the plate. The plate was then transferred to an incubator at 37 °C for 24 h after being incubated at 5 °C for an hour to promote excellent diffusion. By employing a zone reader to measure the size of the clear inhibitory zone surrounding the disc, the antibacterial activity was captured (mm) [56,57].

4.4. DNA Isolation and Molecular Identification of Bacterial Isolates

GeneJetTM Genomic DNA Purification Kit was used to extract the whole genomic DNA from bacterial cells (Thermo Scientific®, Waltham, MA, USA). The procedures were carried out in accordance with the manufacturer’s instructions. Bacterial 16S rDNA was amplified using 27F: 5″–AGAGTTTGATCCTGGCTCAG-3″ and 1492R: 5″GGTTACCTTGTTACGACTT-3″ primers [32,33]. The T100 Thermal Cycler was used to conduct the polymerase chain reaction (PCR) (Bio-Rad, Hercules, CA, USA) using the standard reaction mix (25 µL) containing, 1× PCR buffer, 200 mM of each DNTPS, 15 pmol of each primer, 1-unit Taq polymerase enzyme (Promega® Corporation, Madison, WI, USA), 1.5 mM MgCL2, and 50 ng DNA template. The following thermal cycling parameters were used: initial denaturation at 94 °C for 5 min; 30 cycles of 94 °C for 1 min; 55 °C for 1 min; 72 °C for 1 min; and final elongation at 72 °C for 10 min. Using the QIAquick PCR purification kit from Qiagen (Hilden, Germany), 16S rDNA PCR products were purified before being sequenced at Macrogen Inc., Republic of Korea [58,59,60].

4.5. Phylogenetic Analysis

Using the software DNA STAR, sequence readings were reassembled together (Lasergene, Madison, WI, USA). The taxonomical identification of bacterial isolates was made to the genus level by blasting partial 16S rDNA gene sequences at EzBioCloud (http:l/eztaxon-e.ezbiocloud.net, accessed on 1 April 2020) databases. With the use of Clustal W version, the acquired sequences were aligned at 1.8 [61]. The MEGA X software’s maximum likelihood (ML) algorithm was used to create the 16S rDNA phylogenetic tree [62] using the Tamura-Nei model (q). With 1000 repeats, bootstrap (BT) support for each node was assessed. The percentage of average nucleotide identity (ANI) between tested isolates and closely related reference strains was calculated using the MEGA X software.

4.6. Antimicrobial Inhibitory Effect of Two Potent Bacterial Supernatants Obtained from Hot Spring Waters against Test Pathogenic Bacteria

Agar disc diffusion method was carried out for the determination of the antimicrobial inhibitory effect of the two selected potent bacterial strains obtained from hot spring water. An amount of 25 μL bacterial cultures supernatant were loaded on each paper disc. Test bacterial cultures were inoculated and incubated at 37°C for 24 h. The positive control was chloramphenicol, a broad-spectrum antibiotic against pathogenic bacteria, while the negative control was distilled water. The clear zone diameters around discs were measured [63,64].

4.7. Mutagenesis Using Ethyl Methanesulfonate (EMS)

A total of 5 ml of 48 h old culture of B. licheniformis 113 and B. borstelensis 10 were separately cultivated in nutrient broth and centrifuged (5600 rmp, 4 °C, 3 min). EMS was added to the cell suspension to bring the concentration to 200 mM after the cells were resuspended in 5 mL of sodium phosphate buffer (pH 7.0, 50 mM). For 20, 40, and 60 min, tubes were agitated (100 rpm) at 30 °C. To neutralize the EMS, 500 l of sodium thiosulfate (0.4 M) was then added to the tubes. Centrifugation at (5600 rmp, 10 min) at 4 °C was performed to harvest the cells, which were then washed twice with the same buffer. After being resuspended in phosphate buffer (pH 7.0, 50 mM), the cell pellets were seeded at the proper dilutions (10−1 to 10−6) on the surface of nutrient agar plates. The two chosen powerful strains and/or their EMS mutants were inoculated onto plates, which were then cultured at 50 °C for 48 h using the standard commercial discs loaded with 13 antibiotics. The antibiotic discs used in this study were loaded with the following antibiotics: vancomycin, gentamycin, oxytetracycline, neomycin, tetracycline, rifamycin-SV, polymyxin, norfloxacin, amoxycillin, kanamycin, streptomycin, erythromycin, and chloramphenicol [65].
The new growth of small colonies in the inhibition zones formed around certain antibiotic discs in plates inoculated with bacterial strains treated with EMS were picked and transferred to nutrient agar plates, as they are considered as mutants resistant to this specific antibiotic.

4.8. Assessment of Antimicrobial Activity of the Mutants of B. licheniformis 113 and Br. borstelensis 10

On nutrient agar plates, the isolated colonies of the mutant bacteria were tested against the pathogen microorganisms used before. Each 24 h old (50 µL) pathogenic microorganism was spread and plated after suspension. The discs impregnated with bacterial culture supernatant of the mutants of both bacteria grown for 48 h and centrifuged at 6000 rmp, at 4 °C, for 15 min were placed on the surface of the nutrient agar medium. Each test plate was comprised of four discs. Two mutagen culture supernatant-treated discs were placed at about equal distances from each other on the same plate. Standard antibiotic discs included vancomycin for B. cereus and S. aureus. Tetracycline was used for B. subtilis, M. luteues, and P. ariginosa. Amoxicillin was used for E. coli. Ciprofloxacin was used for S. typhi, while penicillin was used for Klebs. sp. The negative control was 100% DMSO. After that, the plate was incubated for 24 h at 37 °C. The plates were measured for an inhibitory zone diameter after the incubation. For each test, three replicas were employed [66].

4.9. Statistical Analysis

Data were tested for homogeneity of variance using Bartlett’s test, and analysis of variance was used to further evaluate the results (ANOVA). When the ‘F’ test of the ANOVA for treatment was significant at least at the 0.05 probability level, the means were statistically separated on the basis of Duncan’s test (CoHort Software, CoStat version 6.451).

5. Conclusions

Multidrug-resistant pathogenic microorganisms are becoming a serious problem, posing a threat to human health; therefore, there is a need to explore various environmental resources to find microorganisms that are capable of producing antibiotics in sufficient amounts to replace the available antibiotics that lost the efficiency due to the multidrug resistance phenomenon. Harsh environmental conditions are known to allow for the special biodiversity of microbes, and many of them may have potential bioactive compounds. This study explores the presence of potent microbial strains in fifteen sites that are exposed to harsh conditions in a trial to find microbes that are capable of producing antibiotics against eight pathogenic test bacteria. A total of 280 bacterial isolates were obtained from hot spring waters and soils affected by saline conditions. The antibiotic production array showed that 52 isolates (19%) produced antibiotics against one or more of the test bacteria. Two isolates identified as B. licheniformis 113 and Br. borstelensis 10 were potent in the production of antibiotics. Further studies were conducted to enhance the production of antibiotics by these two strains using EMS mutagenesis. The mutants resulting from this mutagenesis step drastically enhanced the antibiotic production against the eight pathogenic test bacteria. This clearly shows the possibilities of obtaining the potent antibiotic-producing bacteria from the harsh environmental sites and the potential of further improving the antibiotic production via strain mutagenesis.

Author Contributions

Conceptualization, Y.G.K.; methodology, W.M.A.E.-R.; software, R.R.G.; validation, N.Y.R.; formal analysis, A.E.-N.A.K. and O.S.B.; investigation, M.Z. and H.M.; data curation, R.R.G.; writing—original draft preparation, W.M.A.E.-R. and N.Y.R.; writing—review and editing, R.R.G. and N.Y.R. All authors have read and agreed to the published version of the manuscript.

Funding

This paper was supported by the RUDN University Strategic Academic Leadership Program.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors acknowledge the scientific and financial support granted by the Egyptian Microbial Culture Collection Network (EMCCN) at the National Research Centre to conduct research for exploring potential antibiotic-producing microbes in extreme environmental conditions in Egypt.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. O’Brien, J.; Wright, G.D. An ecological perspective of microbial secondary metabolism. Curr. Opin. Biotechnol. 2011, 22, 552–558. [Google Scholar] [CrossRef] [PubMed]
  2. Okada, B.K.; Seyedsayamdost, M.R. Antibiotic dialogues: Induction of silent biosynthetic gene clusters by exogenous small molecules. FEMS Microbiol. Rev. 2017, 41, 19–33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Ebou, A.; Koua, D.; Addablah, A.; Kakou-Ngazoa, S.; Dutertre, S. Combined proteotranscriptomic-based strategy to discover novel antimicrobial peptides from cone snails. Biomedicines 2021, 9, 344. [Google Scholar] [CrossRef] [PubMed]
  4. Valarmathi, P. Antibiotics-miracle drugs as crop protectants: A review. Agric. Rev. 2020, 41, 43–50. [Google Scholar] [CrossRef]
  5. Kolter, R.; Van Wezel, G.P. Goodbye to brute force in antibiotic discovery? Nat. Microbiol. 2016, 1, 15020. [Google Scholar] [CrossRef]
  6. Mamun, M.M.; Sorinolu, A.J.; Munir, M.; Vejerano, E.P. Nanoantibiotics: Functions and properties at the nanoscale to combat antibiotic resistance. Front. Chem. 2021, 9, 348. [Google Scholar] [CrossRef]
  7. Aminov, R. History of antimicrobial drug discovery: Major classes and health impact. Biochem. Pharmacol. 2017, 133, 4–19. [Google Scholar] [CrossRef]
  8. Khan, D.A. Proactive management of penicillin and other antibiotic allergies. Allergy Asthma Proc. 2020, 41, 82–89. [Google Scholar] [CrossRef]
  9. Duval, R.E.; Grare, M.; Demoré, B. Fight against antimicrobial resistance: We always need new antibacterials but for right bacteria. Molecules 2019, 24, 3152. [Google Scholar] [CrossRef] [Green Version]
  10. Hu, X.Y.; Logue, M.; Robinson, N. Antimicrobial resistance is a global problem—A UK perspective. Eur. J. Integr. Med. 2020, 36, 101136. [Google Scholar] [CrossRef]
  11. Abd El-Rahim, W.M.; Moawad, H.; Khalafallah, M. Enhancing the growth of promising fungal strains for rapid dye removal. Fresenius Environ. Bull. 2003, 12, 764–770. [Google Scholar]
  12. Abd El-Rahim, W.M.; Moawad, H.; Azeiz, A.Z.A.; Sadowsky, M.J. Biodegradation of azo dyes by bacterial or fungal consortium and identification of the biodegradation products. Egypt. J. Aquat. Res. 2021, 47, 269–276. [Google Scholar] [CrossRef]
  13. Elazm, A.A.; Abd El-Rahim, W.M.; Moawad, H.; Zaki, S.; Sedik, M.Z.; Rostom, M. Bioremediation of hexavalent chromium widely discharged in leather tanning effluents. Egypt. J. Chem. 2020, 63, 2201–2212. [Google Scholar] [CrossRef]
  14. Abd El-Rahim, W.M.; Moawad, H.; Hashem, M.M.; Gebreil, G.M.; Zakaria, M. Highly efficient fungal pectinase and laccase producers among isolates from flax retting liquor. Biocatal. Agric. Biotechnol. 2020, 25, 101570. [Google Scholar] [CrossRef]
  15. Moawad, H.; Abd el-Rahim, W.M.; Abd el-Aleem, D.; Abo Sedera, S.A. Persistence of two Rhizobium etli inoculant strains in clay and silty loam soils. J. Basic Microbiol. Int. J. Biochem. Physiol. Genet. Morphol. Ecol. Microorg. 2005, 45, 438–446. [Google Scholar]
  16. Dafale, N.A.; Srivastava, S.; Purohit, H.J. Zoonosis: An emerging link to antibiotic resistance under “One health approach”. Indian J. Microbiol. 2020, 60, 139–152. [Google Scholar] [CrossRef]
  17. Smith, R.; Russo, J.; Fiegel, J.; Brogden, N. Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails. Antibiotics 2020, 9, 56. [Google Scholar] [CrossRef] [Green Version]
  18. Jakubiec-Krzesniak, K.; Rajnisz-Mateusiak, A.; Guspiel, A.; Ziemska, J.; Solecka, J. Secondary metabolites of actinomycetes and their antibacterial, antifungal and antiviral properties. Pol. J. Microbiol. 2018, 67, 259. [Google Scholar] [CrossRef] [Green Version]
  19. Jaroszewicz, W.; Bielańska, P.; Lubomska, D.; Kosznik-Kwaśnicka, K.; Golec, P.; Grabowski, Ł.; Węgrzyn, A. Antibacterial, antifungal and anticancer activities of compounds produced by newly isolated Streptomyces strains from the Szczelina Chochołowska cave (Tatra Mountains, Poland). Antibiotics 2021, 10, 1212. [Google Scholar] [CrossRef]
  20. Kumar, P.S.; Duraipandiyan, V.; Ignacimuthu, S. Szczelina Chochołowska cave Isolation, screening and partial purification of antimicrobial antibiotics from soil Streptomyces sp. SCA 7. Kaohsiung J. Med. Sci. 2014, 30, 435–446. [Google Scholar] [CrossRef] [Green Version]
  21. Coates, A.R.; Hu, Y.; Holt, J.; Yeh, P. Antibiotic combination therapy against resistant bacterial infections: Synergy, rejuvenation and resistance reduction. Expert Rev. Anti-Infect. Ther. 2020, 18, 5–15. [Google Scholar] [CrossRef] [PubMed]
  22. Moawad, H.; Abd El-Rahim, W.M.; Abd El-Haleem, D. Performance of Phaseolus bean rhizobia in soils from the major production sites in the Nile Delta. Comptes Rendus Biol. 2004, 327, 445–453. [Google Scholar] [CrossRef] [PubMed]
  23. Abd El-Rahim, W.M.; Khalil, W.K.; Eshak, M.G. Evaluation of the gene expression changes in Nile tilapia (Oreochromis niloticus) as affected by the bio-removal of toxic textile dyes from aqueous solution in small-scale bioreactor. Environmentalist 2010, 30, 242–253. [Google Scholar] [CrossRef]
  24. Moawad, H.; Abd El-Rahim, W.M.; Mohamed, W.; Hashem, M.M.; Gebreil, G.M.; Sabbor, A.; Sedik, M.Z. Retting and degumming of flax using biotechnology eco-friendly approach. Egypt. J. Chem. 2019, 62, 2033–2045. [Google Scholar] [CrossRef] [Green Version]
  25. Moawad, H.; Abd El-Rahim, W.M.; Gebreil, G.M.; Hashem, M.M.; Zakaria, M. Historical developments of flax industry for improving fibers quality and fabrics properties. Cut.-Edge Res. Agric. Sci. 2021, 5, 55–74. [Google Scholar]
  26. Yang, H.; Paruch, L.; Chen, X.; van Eerde, A.; Skomedal, H.; Wang, Y.; Liu Clarke, J. Antibiotic application and resistance in swine production in China: Current situation and future perspectives. Front. Vet. Sci. 2019, 6, 136. [Google Scholar] [CrossRef] [Green Version]
  27. De Souza, J.P.; do Prado, C.D.; Eleutherio, E.C.; Bonatto, D.; Malavazi, I.; da Cunha, A.F. Improvement of Brazilian bioethanol production–Challenges and perspectives on the identification and genetic modification of new strains of Saccharomyces cerevisiae yeasts isolated during ethanol process. Fungal Biol. 2018, 122, 583–591. [Google Scholar] [CrossRef]
  28. El-Sherbini, A.; Khattab, A.A. Induction of novel mutants of Streptomyces lincolnensis with high lincomycin production. J. Appl. Pharm. Sci. 2018, 8, 128–135. [Google Scholar]
  29. Osman, Y.; Mowafy, A.; Abdelrazak, A.; El-Mallah, A. Identification of four thermophilic Geobacillus isolates from Hammam Pharaon, Sinai, Egypt. J. Agric. Chem. Biotechnol. 2018, 9, 151–157. [Google Scholar] [CrossRef]
  30. Moubasher, A.H.; Ismail, M.A.; Al-Bedak, O.A.; Mohamed, R.A. Ramophialophora chlamydospora, a new species from an alkaline lake of Wadi-El-Natron. Egypt Asian J. Mycol. 2019, 2, 110–117. [Google Scholar] [CrossRef]
  31. Kimura, R.; Iwasaki, E.; Matsuoka, N. Analysis of the recent agricultural situation of Dakhla Oasis, Egypt, using meteorological and satellite data. Remote Sens. 2020, 12, 1264. [Google Scholar] [CrossRef] [Green Version]
  32. ElSharayidi, M.S.; Dewidar, A.; Shafik, H. Molecular characterization of thermostable hydrolytic Enzymes producing bacteria isolated from hot spring of Ras Sedr, South Sinai, Egypt. Alfarama J. Basic Appl. Sci. 2021, 2, 60–69. [Google Scholar] [CrossRef]
  33. El-Rawy, M.; Abdalla, F.; Negm, A.M. Groundwater Characterization and Quality Assessment in Nubian Sandstone Aquifer, Kharga Oasis, Egypt. In Groundwater in Egypt’s Deserts; Springer: Cham, Switzerland, 2021; pp. 177–199. [Google Scholar]
  34. Hagagy, N.I.; Saddiq, A.A.; Hamedo, H.A.; Selim, S.A. Extremophiles inhabiting unique ecosystems in Egypt. In Extreme Environments; CRC Press: Boca Raton, FL, USA, 2021; pp. 252–262. [Google Scholar]
  35. Panosyan, H. Thermophilic and halophilic prokaryotes isolated from extreme environments of Armenia and their biotechnological potential. In Microbial Versatility in Varied Environments: Microbes in Sensitive Environments; Springer: Berlin/Heidelberg, Germany, 2020; pp. 13–34. [Google Scholar]
  36. Fariq, A.; Yasmin, A. Production, characterization and bioactivities of biosurfactants from newly isolated strictly halophilic bacteria. Process Biochem. 2020, 98, 1–10. [Google Scholar] [CrossRef]
  37. Silvia, S.; Donahue, S.A.; Killeavy, E.E.; Jogl, G.; Gregory, S.T. A Survey of spontaneous antibiotic-resistant mutants of the halophilic, thermophilic bacterium Rhodothermus marinus. Antibiotics 2021, 10, 1384. [Google Scholar] [CrossRef]
  38. Banoon, S.; Ali, Z.; Salih, T. Antibiotic resistance profile of local thermophilic Bacillus licheniformis isolated from Maysan province soil. Comun. Sci. 2020, 11, e3291. [Google Scholar] [CrossRef]
  39. Gahamanyi, N.; Mboera, L.E.; Matee, M.I.; Mutangana, D.; Komba, E.V. Prevalence, risk factors, and antimicrobial resistance profiles of thermophilic Campylobacter species in humans and animals in sub-saharan Africa: A systematic review. Int. J. Microbiol. 2020, 2020, 2092478. [Google Scholar] [CrossRef] [Green Version]
  40. Ak, A.U.; Demirkan, E.; Cengiz, M.; Sevgi, T.; Zeren, B.; Abdou, M. Optimization of culture medium for the production and partial purification and characterization of an antibacterial activity from Brevibacillus laterosporus strain EA62. Rom. Biotechnol. Lett. 2019, 24, 705–713. [Google Scholar]
  41. Halami, P.M. Sublichenin, a new subtilin-like lantibiotics of probiotic bacterium Bacillus licheniformis MCC 2512T with antibacterial activity. Microb. Pathog. 2019, 128, 139–146. [Google Scholar] [CrossRef]
  42. Boovaragamoorthy, G.M.; Anbazhagan, M.; Piruthiviraj, P.; Pugazhendhi, A.; Kumar, S.S.; Al-Dhabi, N.A.; Kaliannan, T. Clinically important microbial diversity and its antibiotic resistance pattern towards various drugs. J. Infect. Public Health 2019, 12, 783–788. [Google Scholar] [CrossRef]
  43. Zhao, S.; Chen, J.; Fei, P.; Feng, H.; Wang, Y.; Ali, M.A.; Yang, W. Prevalence, molecular characterization, and antibiotic susceptibility of Bacillus cereus isolated from dairy products in China. J. Dairy Sci. 2020, 103, 3994–4001. [Google Scholar] [CrossRef]
  44. Ikram-Ul-Haq, S.; Saleem, A.; Javed, M.M. Mutagenesis of Bacillus licheniformis through ethyl methane sulfonate for alpha amylase production. Pak. J. Bot. 2009, 41, 1489–1498. [Google Scholar]
  45. Wang, L.; Xia, Y.; Su, L.; Wu, J. Modification of Bacillus clarkii γ-cyclodextrin glycosyltransferase and addition of complexing agents to increase γ-cyclodextrin production. J. Agric. Food Chem. 2020, 68, 12079–12085. [Google Scholar] [CrossRef] [PubMed]
  46. Rasul, S. Isolation and Mutagenesis of a Bacterial Strain for Enhanced Production and Characterization of Organophosphate Hydrolase. Doctoral Dissertation, University of Agriculture, Faisalabad, Pakistan, 2015. [Google Scholar]
  47. Dat, L.K.; Hien, P.T.T.; Loi, T.T.; Ha, P.T.T. The effect of Ethyl methanesulfonate and Methylsalicylate induced on physiologicaland biochemical characteristics of rice OMCS2000 in anaerobic germination and plant growth under waterlogging. Res. Sq. 2022, 1–21. [Google Scholar] [CrossRef]
  48. Khattab, A.E.N.; Darwish, A.M.; Othman, S.I.; Allam, A.A.; Alqhtani, H.A. Anti-inflammatory and immunomodulatory potency of selenium-enriched probiotic mutants in mice with induced ulcerative colitis. Biol. Trace Elem. Res. 2022, 201, 353–367. [Google Scholar] [CrossRef]
  49. McAuley, S.; Huynh, A.; Howells, A.; Walpole, C.; Maxwell, A.; Nodwell, J.R. Discovery of a novel DNA gyrase-targeting antibiotic through the chemical perturbation of Streptomyces venezuelae sporulation. Cell Chem. Biol. 2019, 26, 1274–1282. [Google Scholar] [CrossRef] [Green Version]
  50. Hindra Pak, P.; Elliot, M.A. Regulation of a novel gene cluster involved in secondary metabolite production in Streptomyces coelicolor. J. Bacteriol. 2010, 192, 4973–4982. [Google Scholar] [CrossRef] [Green Version]
  51. EL-Bondkly, A.M.; Khattab, A.A. Clavulanic acid and cephamycin improvement in Streptomyces clavuligerus by inducing combined resistant mutations and protoplast fusion. Egypt. J. Genet. Cytol. 2004, 33, 217–230. [Google Scholar]
  52. Qattan, S.Y.; Kattab, A.A. Gentamicin production by cultural optimization system and genetically improved mutants of Micromonospora echinospora. Pharmacophore 2020, 11, 15–26. [Google Scholar]
  53. Khalil, M.A.; Beltagy, E.A.; Elshouny, W.A.; El-Naga, E.H.A.; Elshenawy, M.A.; Kelany, M.S. Seasonal bacteriological and physico-chemical analysis of Lake Timsah, Ismailia, Egypt. Life Sci. J. 2014, 11, 10. [Google Scholar]
  54. Mulango, E.; Kasili, R.; Mwirichia, R.; Kambura, A.K.; Muhonja, C. Isolation and characterization of haloalkaliphilic bacteria from the hot springs of Lake Magadi. Afr. J. Microbiol. Res. 2020, 14, 294–302. [Google Scholar]
  55. Mulango, E.M. Isolation and Characterization of Extremophilic Bacteria from the Hot Springs of Lake Magadi, Kenya. Doctoral Dissertation, JKUAT-IBR, Nairobi, Kenya, 2020. [Google Scholar]
  56. Benkova, M.; Soukup, O.; Marek, J. Antimicrobial susceptibility testing: Currently used methods and devices and the near future in clinical practice. J. Appl. Microbiol. 2020, 129, 806–822. [Google Scholar] [CrossRef]
  57. Kortam, Y.G.; Abd El-Rahim, W.M.; Barakat, O.S.; Segai, U.M.; Zakaria, M.; Moawad, H. Optimization of antibiotic production against Bacillus cereus by a mutant strain of Bacillus licheniformis isolated from Egyptian Hamam Pharaon hot springs. Egypt. Pharm. J. 2022, 21, 502. [Google Scholar]
  58. Weisburg, W.G.; Barns, S.M.; Pelletier, D.A.; Lane, D.J. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 1991, 173, 697–703. [Google Scholar] [CrossRef] [Green Version]
  59. Liao, Y.; Chen, J.; Brandt, B.W.; Zhu, Y.; Li, J.; van Loveren, C.; Deng, D.M. Identification and functional analysis of genome mutations in a fluoride-resistant Streptococcus mutans strain. PLoS ONE 2015, 10, e0122630. [Google Scholar] [CrossRef] [Green Version]
  60. Iličić, R.; Jelušić, A.; Marković, S.; Barać, G.; Bagi, F.; Popović, T. Pseudomonas cerasi, the new wild cherry pathogen in Serbia and the potential use of recG helicase in bacterial identification. Ann. Appl. Biol. 2022, 180, 140–150. [Google Scholar] [CrossRef]
  61. Altschul, S.F.; Madden, T.L.; Schäffer, A.A.; Zhang, J.; Zhang, Z.; Miller, W.; Lipman, D.J. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997, 25, 3389–3402. [Google Scholar] [CrossRef] [Green Version]
  62. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular evolutionary genetics analysis across computing platforms. Mol. Biol. Evol. 2018, 35, 1547. [Google Scholar] [CrossRef]
  63. Kaunietis, A.; Buivydas, A.; Čitavičius, D.J.; Kuipers, O.P. Heterologous biosynthesis and characterization of a glycocin from a thermophilic bacterium. Nat. Commun. 2019, 10, 1–12. [Google Scholar]
  64. Tyagi, S.; Singh, R.K.; Tiwari, S.P. Anti-enterococcal and anti-oxidative potential of a thermophilic cyanobacterium, Leptolyngbya sp. HNBGU 003. Saudi J. Biol. Sci. 2021, 28, 4022–4028. [Google Scholar] [CrossRef]
  65. Bazaraa, W.A.; Abd El-Hafez, A.E.N.; Ibrahim, E.M. Mutagenesis and protoplast fusion for enhanced bacteriocins production. Appl. Food Biotechnol. 2021, 8, 133–142. [Google Scholar]
  66. Manandhar, S.; Luitel, S.; Dahal, R.K. In vitro antimicrobial activity of some medicinal plants against human pathogenic chemicals and drugs. BMC Res. Notes 2009, 2, 185. [Google Scholar]
Figure 1. Inhibition zones generated by bacterial isolates No. 10 and 113 against S. typhi and B. sereus pathogenic test microorganisms (four replicates each treatment).
Figure 1. Inhibition zones generated by bacterial isolates No. 10 and 113 against S. typhi and B. sereus pathogenic test microorganisms (four replicates each treatment).
Antibiotics 12 01095 g001
Figure 2. Neighbor-joining (NJ) tree based on 16S rRNA sequences, showing the relationships between hot spring water antibiotic-producing strains and recognized species of B. licheniformis and Br. borstelensis. Bootstrap values are indicated for each node (1000 replicates). Sequences retrieved in this study are shaded.
Figure 2. Neighbor-joining (NJ) tree based on 16S rRNA sequences, showing the relationships between hot spring water antibiotic-producing strains and recognized species of B. licheniformis and Br. borstelensis. Bootstrap values are indicated for each node (1000 replicates). Sequences retrieved in this study are shaded.
Antibiotics 12 01095 g002
Figure 3. Antimicrobial inhibitory effect of B. licheniformis supernatant against B. cereus.
Figure 3. Antimicrobial inhibitory effect of B. licheniformis supernatant against B. cereus.
Antibiotics 12 01095 g003
Figure 4. Water sample locations.
Figure 4. Water sample locations.
Antibiotics 12 01095 g004
Table 1. Physical and chemical analysis of waters collected from hot springs and soils affected by hot spring waters and salinity conditions.
Table 1. Physical and chemical analysis of waters collected from hot springs and soils affected by hot spring waters and salinity conditions.
Sample TypeSample No.Sampling SitesTemp.
°C
EC dS/mDissolved Cations
mEq/L
Dissolved Anions
mEq/L
Ca2+Mg2+Na+K+HCO3−ClSO42−
Water1Hot spring at Ras Sedr, Sinai907.0513.253301312.1613083.34
2Hot spring at El-Baida Lake, Wadi El-Natrun608.1617.58811.5211.81723.7
3Suez Gulf, Sinai257.6863.131138745.31.8643274.1
4Salinity Al-Gaar Lake, Wadi El-Natrun289.271771301901456110162053.2
5Salinity El-Hamara Lake, Wadi El-Natrun288.0232955116.5248839.6259234.1
6 *Hammam Pheraon hot springs (entrance)507.0725.16228220.30.925062.5
7 *Hammam Pheraon hot springs (inside)557.6927.58444268.11.3285113.2
8 *Ras Sedr sulfur hot spring907.0515.3747161010.711451.4
9 *Dakhla Oasis hot spring518.164.28811.5211.81723.7
10 *Kharga Oasis hot spring559.660.71223.51.342.32
Soils11Inside hot spring of Hammam Pharaon, Sinai557.7829.28947287.61.9321124
12El-Baida Lake, Wadi El-Natrun609.6619.12223.51.342.32
13Rhizosphere samples from the Suez Gulf coast, Sinai307.8365.438.41468732.9759298
14Salinity Al-Gaar Lake, Wadi El-Natrun,289.041811361971489117169061.5
15Salinity El-Hamara Lake, Wadi El-Natrun,288.1835861127261743.8261938.5
* Due to the unique properties of the geothermal water samples and, consequently, the prevailing microbiota, the analysis of the samples was made accessible to several researchers exploring the biotechnological potentials of the thermophilic microorganisms. The collected water samples 6, 7, 8, 9, and 10 were analyzed in the laboratory of Egyptian Microbial Culture Collection Network (EMCCN) at the Egyptian National Research Center branch (http:emccn.eg.net, accessed on 1 October 2019).
Table 2. Antibiotic-producing bacterial isolates from hot spring waters and saline soils.
Table 2. Antibiotic-producing bacterial isolates from hot spring waters and saline soils.
Sample TypeSample SitesSample
Number
Production of Antibiotics against 8 Pathogenic Test Microorganisms *17
PositiveNegative
WaterRas Sedr hot spring, Sinai 151217
El-Baida Lake hot spring, Wadi El-Natrun 231013
Suez Gulf, Sinai 341317
Salinity Al-Gaar Lake, Wadi El-Natrun 411718
Salinity El-Hamara Lake, Wadi El-Natrun 532124
Hammam Pheroon hot springs (entrance) 65712
Hammam Pheroon hot springs (inside) 741115
Ras Sedr sulfur hot spring821618
Dakhla Oasis hot spring 96713
Kharga Oasis hot spring 1051419
SoilsHammam Pharaon hot spring, Sinai 1171825
El-Baida Lake, Wadi El-Natrun 1221719
Rhizosphere samples from the Suez Gulf coast, Sinai 1331619
Al-Gaar Lake, Wadi El-Natrun, 1412324
El-Hamara Lake, Wadi El-Natrun, 1512627
Totals--52228280
* Pathogenic test microorganisms are Klebsiella pneumonia, Escherichia coli, Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, Micrococcus luteus, Pseudomonas aeroginosa, and Salmonella typhimurium.
Table 3. Antibiotic production profiles (APP) of thermophilic and halophilic isolates against 8 pathogenic test microorganisms.
Table 3. Antibiotic production profiles (APP) of thermophilic and halophilic isolates against 8 pathogenic test microorganisms.
Isolate SourceIsolate NumberSample SitesPathogenic Test BacteriaSpectrum of Antagonism against 8 Pathogens
B. cereusB. subtilisE. coliS. typhiKlebs sp.S. aureusM. luteusP. ariuginosa
Water10Kharga Oasis 1 *++++++++8
113Hammam Pheraon 1++++++++8
118, 116El-Hamara Lake 1+++++++7
9, 11Dakhla Oasis 1++++++6
131, 124Ras Sedr 1+++++++7
111Hammam Pheraon 1++++++6
109, 108Suez Gulf 1++++++6
19Dakhla Oasis 1++++++6
112Hammam Pheraon 1++++++6
121, 123Hammam Pheraon 2*+++++5
123, 149Suez Gulf 1++++4
114, 126El-Baida Lake 1+++++5
120El-Hamara Lake 1+++++5
122Ras Sedr 1+++++5
22, 20, 13Dakhla Oasis 1+++++5
119, 124Hammam Pheroon 1+++++5
115, 125Ras Sedr 1+++++5
3, 8Kharga Oasis 1+++++5
25Ras Sedr sulfur 2+++++5
141, 143Hammam Pheraon 2+++++5
191Ras Sedr sulfur 2+++++5
155Al-Gaar Lake 1++2
147El-Baida Lake 1++2
1, 5Kharga Oasis 1+1
Soils136, 138Hammam Pharaon 3*+++++5
130Al-Gaar Lake 2++++4
135, 127Hammam Pharaon 3+++++++7
225El-Baida Lake 2++++4
128Hammam Pharaon 3+++++5
158Suez Gulf coast 2+++++5
229El-Baida Lake 2+++++5
182, 23Hammam Pharaon 3++++4
157, 154Suez Gulf coast 2+++3
184El-Hamara Lake 2++2
156Hammam Pharaon 3+1
* 1,2,3 is number of sample sites, + is positive inhibition, − is negative inhibition.
Table 4. Antimicrobial inhibitory effect of culture supernatant (25 μL) obtained from B. licheniformis 113 and Br. borstelensis 10 against 8 test pathogenic bacteria.
Table 4. Antimicrobial inhibitory effect of culture supernatant (25 μL) obtained from B. licheniformis 113 and Br. borstelensis 10 against 8 test pathogenic bacteria.
Test BacteriaMIE of Bacterial Culture Supernatant (μL) Containing (AM)
B. licheniformis 113Br. borstelensis 10
B. cereus155
B. subtilis1010
E. coli1510
S. typhimurium1015
K. pneumonia2010
S. aureus510
M. luteus1015
P. aeruginosa525
Table 5. Susceptibility of B. licheniformis 113 and Br. borstelensis 10 to 13 commercial antibiotics.
Table 5. Susceptibility of B. licheniformis 113 and Br. borstelensis 10 to 13 commercial antibiotics.
Bacterial Strains Diameter of Inhibition Zone (mm)
VAN
+30
GEN
10
OTC
10
NEO
5
Tet
30
R-SV
30
PM-B
300
NOR
10
AMX
25
KAN
30
STR
10
ERY
15
C
10
B. licheniformis, 113011008261612800018
Br. borstelensis, 10081289091601301524
VAN, vancomycin; GEN, gentamycin; OTC, oxytetracycline; NEO, neomycin; Tet, tetracycline; R-SV, rifamycin-SV; PM-B, polymyxin B; NOR; norfloxacin; AMX, amoxycillin; KAN, kanamycin; STR, streptomycin; ERY, erythromycin; C, chloramphenicol. + Concentration (µg/disc). The values are means of diameter of inhibition zones (mm) around discs.
Table 6. Total plate count (CFU) of mutant bacterial strains by EMS-mutagenesis at different shaking period.
Table 6. Total plate count (CFU) of mutant bacterial strains by EMS-mutagenesis at different shaking period.
Period
(min)
B. licheniformis 113Br. borstelensis 10
Count
CFU/mL
Survival
%
Count
CFU/mL
Survival
%
078 × 106100169 × 106100
2045 × 10657.762 × 10636.6
4038 × 10648.814 × 1068.3
6011 × 10641.28 × 1064.8
Table 7. Antagonistic activity of mutant strain B. licheniformis 113 against the test bacteria.
Table 7. Antagonistic activity of mutant strain B. licheniformis 113 against the test bacteria.
Mutant StrainsInhibition Zone (mm) with Test Pathogenic Bacteria
B. cereusaB. subtilisbE. coliaS. typhicK. pneumoniabS. aureusdM. luteuscP. aeruginosaa
Parent h22 la ± 0.0519 mc ± 0.0022 ja ± 0.0010 je ± 0.0517 ld ± 0.008 lf ± 0.05kf ± 0.0021 lb ± 0.00
* M1/Van ef31 da ± 0.0524 id ± 0.0028 eb ± 0.0516 ef ± 0.0023 ge ± 0.0013 gg ± 0.0511 jh ± 0.0026 hc ± 0.05
M2/Van fg26 hb ± 0.0026 gb ± 0.0024 hd ± 0.0013 ge ± 0.0528 da ± 0.009 kf ± 0.0013 ie ± 0.0525 ic ± 0.00
M3/Van g24 ja ± 0.0023 jb ± 0.0024 ha ± 0.0018 dd ± 0.0019 kc ± 0.0011 if ± 0.0017 ee ± 0.0024 ja ± 0.00
M4/Van fg30 ea ± 0.0025 hc ± 0.0524 hd ± 0.0012 hg ± 0.0024 fd ± 0.0015 ee ± 0.0514 hf ± 0.0027 gb ± 0.10
M5/Gen fg23 kb ± 0.0523 jb ± 0.0026 fa ± 0.0014 fc ± 0.0026 ea ± 0.059 ke ± 0.0011 jd ± 0.0026 ha ± 0.00
M6/Oxy efg29 fb ± 0.0524 id ± 0.0025 gc ± 0.0514 ff ± 0.0023 ge ± 0.0512 hg ± 0.0011 jh ± 0.0032 ca ± 0.00
M7/Oxy g24 jc ± 0.0020 le ± 0.0023 id ± 0.0013 gg ± 0.0526 eb ± 0.0014 ff ± 0.0014 hf ± 0.0529 ea ± 0.00
M8/Neo b33 ba ± 0.0032 bb ± 0.0033 ba ± 0.1022 bd ± 0.0031 bc ± 0.0021 be ± 0.0522 bd ± 0.0033 ba ± 0.00
M9/Neo efg26 hb ± 0.0523 jc ± 0.0026 fb ± 0.0511 ie ± 0.0029 ca ± 0.009 kf ± 0.0519 dd ± 0.0023 kc ± 0.00
M10/Tetra de24 jc ± 0.0022 kd ± 0.0526 fb ± 0.0021 ce ± 0.0031 ba ± 0.0017 cf ± 0.0016 fg ± 0.0526 hb ± 0.05
M11/Kan efg29 fb ± 0.0030 da ± 0.0528 ec ± 0.0012 hg ± 0.0522 he ± 0.059 kh ± 0.0014 hf ± 0.0023 kd ± 0.05
M12/Kan fg25 ic ± 0.0026 gb ± 0.0031 ca ± 0.0014 fg ± 0.0520 je ± 0.0014 fg ± 0.0017 ef ± 0.0023 kd ± 0.05
M13/Str ef25 ic ± 0.0525 hc ± 0.0028 eb ± 0.0016 ee ± 0.0023 gd ± 0.0010 jg ± 0.0514 hf ± 0.0529 ea ± 0.00
M14/Chl ef28 ga ± 0.0028 ea ± 0.0024 hc ± 0.0014 fe ± 0.0026 eb ± 0.0511 if ± 0.0015 gd ± 0.0026 hb ± 0.00
M15/Amo a36 aa ± 0.0033 ac ± 0.0035 ab ± 0.0024 ae ± 0.0533 ac ± 0.0025 ad ± 0.0024 ae ± 0.0036 aa ± 0.00
M16/Ery d25 ic ± 0.0031 ca ± 0.0528 eb ± 0.0518 df ± 0.0021 id ± 0.0016 dg ± 0.0020 ce ± 0.0028 fb ± 0.05
M17/Ery c32 ca ± 0.0527 fd ± 0.0030 dc ± 0.0014 ff ± 0.0031 bb ± 0.0014 ff ± 0.0515 ge ± 0.0031 db ± 0.00
* Means, followed by different superscripts (within columns) and different subscripts (within rows) are significantly different (p < 0.05).
Table 8. Antagonistic activity of mutant strain Br. borstelensis 10 against test bacteria.
Table 8. Antagonistic activity of mutant strain Br. borstelensis 10 against test bacteria.
Mutant StrainsInhibition Zones (mm) of Test Pathogenic Bacteria
B. cereusbB. subtiliscdE. coliaS. typhifK. pneumoniaeS. aureusgM. luteusdeP. aeruginosabc
Parent f23 kb ± 0.0019 ke ± 0.0525 ka ± 0.0018 lf ± 0.0519 he ± 0.0011 ig ± 0.0520 md ± 0.0021 hc ± 0.00
* B1/Van e27 ga ± 0.1023 hd ± 0.0027 ia ± 0.0023 id ± 0.0026 eb ± 0.0013 hf ± 0.0022 le ± 0.0025 fc ± 0.05
B2/Van e24 jc ± 0.0024 gc ± 0.0529 ga ± 0.0026 fb ± 0.0023 gd ± 0.0516 ee ± 0.0523 kd ± 0.0026 eb ± 0.00
B3/Gen bcd28 fc ± 0.0529 eb ± 0.0032 ea ± 0.0019 k ± 0.0224 fe ± 0.0518 cf ± 0.0027 gd ± 0.0528 dc ± 0.00
B4/Gen bcd32 db ± 0.0022 ig ± 0.0034 ca ± 0.0528 dc ± 0.0027 dd ± 0.0013 hh ± 0.0023 k f ± 0.0026 ee ± 0.05
B5/Neo bcd26 he ± 0.0032 ca ± 0.0031 fb ± 0.0025 gf ± 0.0529 cc ± 0.0016 eh ± 0.0528 fd ± 0.0023 gg ± 0.00
B6/Neo d26 hc ± 0.0025 fd ± 0.0028 hb ± 0.0021 je ± 0.0526 ec ± 0.0013 hf ± 0.0026 hc ± 0.0534 ba ± 0.00
B7/Neo a36 aa ± 0.0534 ab ± 0.0036 aa ± 0.0033 ac ± 0.0023 gd ± 0.0520 be ± 0.0534 ab ± 0.0036 aa ± 0.00
B8/Tetra d25 id ± 0.0029 ec ± 0.0033 da ± 0.0520 kf ± 0.0024 fe ± 0.0015 fg ± 0.0024 je ± 0.0031 cb ± 0.00
B9/Rif bc25 if ± 0.0031 db ± 0.0526 je ± 0.0029 cc ± 0.0532 aa ± 0.0013 hh ± 0.0524 jg ± 0.0028 dd ± 0.05
B10/Rif b29 ec ± 0.0034 aa ± 0.0527 id ± 0.0524 hg ± 0.0531 bb ± 0.0014 gh ± 0.0025 if ± 0.0026 ee ± 0.05
B11/Poly a34 bb ± 0.0033 bc ± 0.0035 ba ± 0.0032 bd ± 0.0032 ad ± 0.0522 ae ± 0.0032 bd ± 0.0534 bb ± 0.00
B12/Poly cd33 ca ± 0.0523 hf ± 0.0032 eb ± 0.0519 kg ± 0.0026 ed ± 0.0017 dh ± 0.0529 ec ± 0.1025 fe ± 0.00
B13/Amo cd27 gc ± 0.0521 jg ± 0.0035 ba ± 0.0025 ge ± 0.0026 ed ± 0.0216 eh ± 0.0030 db ± 0.0023 gf ± 0.05
B14/Stre bcd24 jf ± 0.0025 fe ± 0.0535 ba ± 0.0027 ed ± 0.0523 gg ± 0.0015 fh ± 0.0031 cb ± 0.0028 dc ± 0.00
* Means, followed by different superscripts (within columns) and different subscripts (within rows) are significantly different (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kortam, Y.G.; Abd El-Rahim, W.M.; Khattab, A.E.-N.A.; Rebouh, N.Y.; Gurina, R.R.; Barakat, O.S.; Zakaria, M.; Moawad, H. Enhancing the Antibiotic Production by Thermophilic Bacteria Isolated from Hot Spring Waters via Ethyl Methanesulfonate Mutagenesis. Antibiotics 2023, 12, 1095. https://doi.org/10.3390/antibiotics12071095

AMA Style

Kortam YG, Abd El-Rahim WM, Khattab AE-NA, Rebouh NY, Gurina RR, Barakat OS, Zakaria M, Moawad H. Enhancing the Antibiotic Production by Thermophilic Bacteria Isolated from Hot Spring Waters via Ethyl Methanesulfonate Mutagenesis. Antibiotics. 2023; 12(7):1095. https://doi.org/10.3390/antibiotics12071095

Chicago/Turabian Style

Kortam, Yasmin G., Wafaa M. Abd El-Rahim, Abd El-Nassar A. Khattab, Nazih Y. Rebouh, Regina R. Gurina, Olfat S. Barakat, Mohamed Zakaria, and Hassan Moawad. 2023. "Enhancing the Antibiotic Production by Thermophilic Bacteria Isolated from Hot Spring Waters via Ethyl Methanesulfonate Mutagenesis" Antibiotics 12, no. 7: 1095. https://doi.org/10.3390/antibiotics12071095

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop